NCT00651885View on ClinicalTrials.gov

Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Critical Limb Ischemia
Interventions
DRUG

treprostinil dienthanolmine sustained release

UT-15C SR 1mg tablet

DRUG

Placebo

Placebo

Trial Locations (1)

70121

Ochsner Clinic Foundation, New Orleans

Sponsors

Collaborators (1)

United Therapeutics
All Listed Sponsors
collaborator

United Therapeutics

INDUSTRY

lead

Ochsner Health System

OTHER